Catalogue
Real-world health concerns mapped to the compounds researched in their context — ranked by relevance, with the evidence and the caveats spelled out. A starting point for understanding, not a treatment plan.
Degeneration and pain of the Achilles tendon — a classic target for tendon-repair peptide interest.
2 compounds researched
Persistent low-back pain — where anti-inflammatory and neuropathic-pain compounds are explored alongside the mainstays.
3 compounds researched
Adhesive capsulitis — painful, progressive shoulder stiffness where anti-inflammatory and repair peptides are explored.
2 compounds researched
Degenerative cartilage wear in the knee — where repair and anti-inflammatory compounds draw interest.
3 compounds researched
Tears and tendinopathy of the shoulder's rotator cuff — one of the most common reasons people look into repair peptides.
3 compounds researched
Lateral epicondylitis — overuse tendinopathy of the elbow where repair peptides are commonly discussed.
2 compounds researched
Blunted insulin sensitivity — the metabolic precursor where lifestyle compounds and incretins are explored.
3 compounds researched
Fat accumulation in the liver — where metabolic and antioxidant compounds are studied.
3 compounds researched
Clinically significant excess body fat — where incretin medicines have changed the landscape.
3 compounds researched
Insulin-resistant high blood sugar — the condition GLP-1 medicines were built for.
4 compounds researched
Crohn's and ulcerative colitis — chronic gut inflammation where anti-inflammatory peptides draw interest.
2 compounds researched
Functional gut disorder with pain and altered bowels — where gut-lining and anti-inflammatory peptides are discussed.
2 compounds researched
Increased intestinal permeability — the most common reason people look into gut-lining peptides.
2 compounds researched
Normal aging-related slips in memory and processing — where neurotrophic and longevity compounds are studied.
3 compounds researched
Subjective mental cloudiness and poor focus — where nootropic peptides and wakefulness agents are explored.
3 compounds researched
Profound, persistent fatigue — where mitochondrial, immune, and low-dose naltrexone approaches are explored.
4 compounds researched
Difficulty falling or staying asleep — where sleep peptides and low-risk supplements are explored.
3 compounds researched